Biocon Gains Over 1% as Subsidiary Signs Settlement and License Deal with Amgen | Udaipur Kiran

Mumbai (Udaipur Kiran News): Shares of Biocon Ltd rose over 1.6% in Wednesday’s trading session after its subsidiary, Biocon Biologics, signed a settlement and license agreement with Amgen Inc. paving the way for the commercial launch of its biosimilar drugs Bosaya (denosumab-kyqq) and Aukelso (denosumab-kyqq) in the United States. The stock was trading at ₹346.35, […]

Read More

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street

Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs […]

Read More